Bryan Johnson gets blood work done every few months to track 63 biomarkers, half standard clinical tests and half custom metrics tied to his specific treatments. He's using human growth hormone to regenerate his thymus and watches his IGF-1 level, which has risen above 150, to see if the therapy is actually working.
Hi, everyone. Today is blood draw day. I'm excited. I love it. Yes, I'm going to get poked. But you know what? It's part of the process and I love getting the results. It really tells us if the things we're doing are working or not working. And we get to see closed loop, what's working and what's not. Today we're going to draw quite a bit of blood. It's 63 biomarkers we're looking at. About 35 or so are standard things we look at on a routine basis, and about 35 are things we're looking at in particular as we're tracking various therapies. For example, I started human growth hormones, hgh, to regenerate my thymus, which is responsible for my immune system. And so one of the markers we're looking at is IGF1. Since starting HGH, my IGF levels have increased just above 150 on this last draw. So we're looking to see if it's continuing to increase, if it's steady or if it's going to decline.
